000			01991na a2200241 4500
003			H12O
005			20180417112620.0
008			130622s2011 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aHitt Sabag, Ricardo _91474 _eOncología Médica
100			_aHomet, Blanca _91788 _eOncología Médica
245	0	0	_aUpdate on the diagnosis of cancer of unknown primary (CUP) origin _h[artículo]
260			_bClinical and Translational Oncology, _c2011
300			_a13(7):434-441.
500			_aFormato Vancouver: Ariza A, Balañá C, Concha Á, Hitt R, Homet B, Matilla A, Alba E. Update on the diagnosis of cancer of unknown primary (CUP) origin. Clin Transl Oncol. 2011Jul;13(7):434-41.
501			_aPMID: 21775269
504			_aContiene 43 referencias
520			_aThe cancer of unknown primary (CUP) concept encompasses a heterogeneous group of cancers that are difficult to diagnose and that show diverse clinical and histopathological features. Currently, CUP is the fifth most frequent cancer diagnosis in women and the eighth in men. The ongoing development of new therapies specific to the various cancer types makes mandatory the identification of the primary tumour in CUP patients, so that they may benefit from advances in therapy and improvements in prognosis. Molecular detection techniques provide very useful tools in the prediction of primary tumour types and must be used together with clinical, histopathological and IHC diagnostic techniques. Steady collaboration and fluid communication between oncologists and pathologists is of the utmost importance for the correct interpretation of tests and the personalised approach required by each individual case. Work in multidisciplinary teams will result in significant changes in the diagnosis and treatment of these patients.
710			_9303 _aServicio de Oncología Médica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6834.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c6834 _d6834